National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 11/19/2021 release of VAERS data:

This is VAERS ID 1738765

Government Disclaimer on use of this data

Case Details

VAERS ID: 1738765 (history)  
Form: Version 2.0  
Age: 20.0  
Sex: Male  
Location: Foreign  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Pyrexia, SARS-CoV-2 test
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC202101211370

Write-up: Shortness of breath; I noticed a shortness of breath occur when I started to walk up stairs or exert myself, which got gradually worse, but not debilitating.; Fever; This is a spontaneous report from a contactable consumer received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202109140816008880-MYONW. Sender''s (Case) Safety Report Unique Identifier is GB-MHRA-ADR 25937279. A 20-year-old male patient received second dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH, Formulation: Solution for injection, Lot number was not reported), via an unspecified route of administration on 11Sep2021, (at the age of 20-year-old) as dose 2, single for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH, Formulation: Solution for injection, Lot number was not reported), as dose 1, single for COVID-19 immunization. On 13Sep2021, the patient experienced shortness of breath. On 11Sep2021, the patient had fever. It was also reported that she suffered an intense but short-lasting fever the night after. However, when he went back to work the day after, he noticed a shortness of breath occur when he started to walk upstairs or exert himself (dyspnoea exacerbated), which got gradually worse, but not debilitating. No notable chest pains or palpitations occurred. Patient has not tested positive for COVID-19 since having the vaccine. Patient was not enrolled in clinical trial. The patient underwent lab tests and procedures which included sars-cov-2 test negative, No - Negative COVID-19 test. On 12Sep2021, the outcome of the event fever was reported as resolved, dyspnoea was not recovered and dyspnoea exacerbated was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

New Search

Link To This Search Result:

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166